Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 3;60(3):472-489.e8.
doi: 10.1016/j.devcel.2024.10.009. Epub 2024 Nov 7.

FoxA1/2-dependent epigenomic reprogramming drives lineage switching in lung adenocarcinoma

Affiliations

FoxA1/2-dependent epigenomic reprogramming drives lineage switching in lung adenocarcinoma

Katherine Gillis et al. Dev Cell. .

Abstract

The ability of cancer cells to undergo identity changes (i.e., lineage plasticity) plays a key role in tumor progression and response to therapy. Loss of the pulmonary lineage specifier NKX2-1 in KRAS-driven lung adenocarcinoma (LUAD) enhances tumor progression and causes a FoxA1/2-dependent pulmonary-to-gastric lineage switch. However, the mechanisms by which FoxA1/2 activate a latent gastric identity in the lung remain largely unknown. Here, we show that FoxA1/2 reprogram the epigenetic landscape of gastric-specific genes after NKX2-1 loss in mouse models by facilitating ten-eleven translocation (TET)2/3 recruitment, DNA demethylation, histone 3 lysine 27 acetylation (H3K27ac) deposition, and three-dimensional (3D) chromatin interactions. FoxA1/2-mediated DNA methylation changes are highly conserved in human endodermal development and in progression of human lung and pancreatic neoplasia. Furthermore, oncogenic signaling is required for specific elements of FoxA1/2-dependent epigenetic reprogramming. This work demonstrates the role of FoxA1/2 in rewiring the DNA methylation and 3D chromatin landscape of NKX2-1-negative LUAD to drive cancer cell lineage switching.

Keywords: FOXA1/2; TET2/3; cancer lineage switching/plasticity; epigenetic reprogramming; lung adenocarcinoma.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Update of

References

    1. Natoli G (2010). Maintaining cell identity through global control of genomic organization. Immunity 33, 12–24. 10.1016/j.immuni.2010.07.006. - DOI - PubMed
    1. Tata PR, and Rajagopal J (2016). Cellular plasticity: 1712 to the present day. Curr. Opin. Cell Biol 43, 46–54. 10.1016/j.ceb.2016.07.005. - DOI - PMC - PubMed
    1. Thankamony AP, Subbalakshmi AR, Jolly MK, and Nair R (2021). Lineage Plasticity in Cancer: The Tale of a Skin-Walker. Cancers (Basel) 13. 10.3390/cancers13143602. - DOI - PMC - PubMed
    1. Li X, Karras P, Torres R, Rambow F, van den Oord J, Marine JC, and Kos L (2020). Disseminated Melanoma Cells Transdifferentiate into Endothelial Cells in Intravascular Niches at Metastatic Sites. Cell Rep 31, 107765. 10.1016/j.celrep.2020.107765. - DOI - PubMed
    1. Zewdu R, Mehrabad EM, Ingram K, Fang P, Gillis KL, Camolotto SA, Orstad G, Jones A, Mendoza MC, Spike BT, and Snyder EL (2021). An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma. eLife 10. 10.7554/eLife.66788. - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources